An Matheeussen

Wilrijk, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

Journal: ACS medicinal chemistry letters

Published: April 13, 2026

Late-Stage Diversification of Rewired Purine C-Nucleosides Reveals Potent Antitrypanosomatid Agents with In Vivo Efficacy.

Late-Stage Diversification of Rewired Purine C-Nucleosides Reveals Potent Antitrypanosomatid Agents with In Vivo Efficacy.

Journal: Journal of medicinal chemistry

Published: April 03, 2026

Multifaceted biological and computational assessment of aromatic and N-heteroaromatic non-substituted thiosemicarbazones.

Multifaceted biological and computational assessment of aromatic and N-heteroaromatic non-substituted thiosemicarbazones.

Journal: Scientific reports

Published: January 14, 2026

Isolation and characterization of antiplasmodial and antimicrobial compounds from Tetracera alnifolia using a bioassay-guided approach.

Isolation and characterization of antiplasmodial and antimicrobial compounds from Tetracera alnifolia using a bioassay-guided approach.

Journal: RSC advances

Published: December 08, 2025

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs.

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs.

Journal: ChemMedChem

Published: October 22, 2025

Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.

Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.

Journal: ACS infectious diseases

Published: August 11, 2025

Discovery and Development of an Advanced Lead for the Treatment of African Trypanosomiasis.

Discovery and Development of an Advanced Lead for the Treatment of African Trypanosomiasis.

Journal: ACS infectious diseases

Published: December 12, 2024

Discovery of a Series of Macrocycles as Potent Inhibitors of Leishmania Infantum.

Discovery of a Series of Macrocycles as Potent Inhibitors of Leishmania Infantum.

Journal: Journal of medicinal chemistry

Published: October 08, 2024

N-Pyrazolyl- and N-Triazolylamines and -Ureas as Antileishmanial and Antitrypanosomal Drugs.

N-Pyrazolyl- and N-Triazolylamines and -Ureas as Antileishmanial and Antitrypanosomal Drugs.

Journal: ChemMedChem

Published: March 27, 2024

Design and Synthesis of 1,3-Diarylpyrazoles and Investigation of Their Cytotoxicity and Antiparasitic Profile.

Design and Synthesis of 1,3-Diarylpyrazoles and Investigation of Their Cytotoxicity and Antiparasitic Profile.

Journal: International journal of molecular sciences

Published: February 26, 2024

Late-Stage Diversification of Pyrazoles as Antileishmanial Agents.

Late-Stage Diversification of Pyrazoles as Antileishmanial Agents.

Journal: ChemMedChem

Published: January 08, 2024

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1.

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1.

Journal: Science translational medicine

Published: December 13, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026